These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


363 related items for PubMed ID: 3044834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB.
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
    Di Filippo F, Rossi CR, Santinami M, Cavaliere F, Garinei R, Anzà M, Perri P, Botti C, Di Angelo P, Pasqualoni R, Di Filippo S.
    In Vivo; 2006 Apr; 20(6A):739-42. PubMed ID: 17203758
    [Abstract] [Full Text] [Related]

  • 8. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF.
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [Abstract] [Full Text] [Related]

  • 9. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.
    Storm FK, Sparks FC, Morton DL.
    Surg Gynecol Obstet; 1979 Jul; 149(1):17-21. PubMed ID: 451822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
    Knorr C, Meyer T, Janssen T, Goehl J, Hohenberger W.
    Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET.
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract] [Full Text] [Related]

  • 18. [Hyperthermic-antiblastic isolation perfusion for advanced melanoma of the limbs. The technic, immediate results and a review of the literature].
    Decian F, Balletto N, Camerini G, Depaoli M, D'Aniello R, Ameri A, Brisighella A, Bonalumi U, Bachi V, Civalleri D.
    Minerva Chir; 1990 Oct 15; 45(19):1227-37. PubMed ID: 2074944
    [Abstract] [Full Text] [Related]

  • 19. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
    Barbour AP, Thomas J, Suffolk J, Beller E, Smithers BM.
    Ann Surg Oncol; 2009 Dec 15; 16(12):3463-72. PubMed ID: 19830498
    [Abstract] [Full Text] [Related]

  • 20. Results of 206 isolated limb perfusions for malignant melanoma.
    Lejeune FJ, Liénard D, el Douaihy M, Seyedi JV, Ewalenko P.
    Eur J Surg Oncol; 1989 Dec 15; 15(6):510-9. PubMed ID: 2599121
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.